Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions by Yongming Jin, Fei Chen, Gang Xu, Chaogang Wei, Congsong Dong

Subjects: Get full text

3D-AttenNet model can predict clinically significant prostate cancer in PI-RADS category 3 patients: a retrospective multicenter study by Jie Bao, Litao Zhao, Xiaomeng Qiao, Zhenkai Li, Yanting Ji, Yueting Su, Libiao Ji, Junkang Shen, Jiangang Liu, Jie Tian, Ximing Wang, Hailin Shen, Chunhong Hu

Subjects: Get full text

Ultra-fast biparametric MRI in prostate cancer assessment: Diagnostic performance and image quality compared to conventional multiparametric MRI by Antonia M. Pausch, Vivien Filleböck, Clara Elsner, Niels J. Rupp, Daniel Eberli, Andreas M. Hötker

Subjects: Get full text

Malacoplaquia prostática diagnosticada como lesión PI-RADS 5 asociada a absceso prostático en paciente inmunocompetente by Luis D. Nuño-Uscanga, José B. Cisneros-Madrid, Alejandro Madero-Arteaga, José P. Lomelín-Ramos, Yeni Fernández de Lara-Barrera, Danny R. Soria-Céspedes, Brandon Martínez-Torres, Juan P. López-Calderón

Subjects: “…Absceso prostático. Michaelis-Gutmann. PI-RADS 5.…”
Get full text